Concepedia

Publication | Open Access

hERG1 and HIF-2α Behave as Biomarkers of Positive Response to Bevacizumab in Metastatic Colorectal Cancer Patients

DOIFull Paper Access

22

Citations

26

References

2020

Year

Jessica Iorio, Elena Lastraioli, Lorenzo Tofani, Giulia Petroni, Lorenzo Antonuzzo, Luca Messerini, Giuseppe Perrone, Damiano Caputo, Maria Francesconi, Maria Michelina Amato,
Translational Oncology

Abstract

hERG1 and aHIF-2α might help to identify patients who would benefit from bevacizumab treatment.

References

YearCitations

Page 1